Ascelia Pharma

Major Shareholding Notification • May 2, 2019

Issuer Ascelia Pharma AB

Holder

Sunstone Life Science Ventures II K/S

Instrument

Instrument Ordinary shares SE0010573113 Before the transaction Shares Data not given* Voting rights Data not given* Transaction Reason for major shareholding notification Other Date 29/04/2019 Limit for number of shares 15 % Limit for number of votes 15 % After the transaction Quantity Shares 4,497,699 Directly held voting rights 4,497,699 Indirectly held voting rights 0 Percentage Directly held shares 19.14818 % Directly held voting rights 19.14818 % Indirectly held voting rights 0 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	19.14818 %	4,497,699
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total	19.14818 %	4,497,699
Group total holdings
Voting rights 4,497,699
Percentage of voting rights 19.14818
Notes (other relevant informations according to law)
Flaggningen avser ändrad sammansättning av Sunstone Life Science Ventures II K/S position,

till följd av att aktier som före Ascelia Pharma AB:s börsnotering utlånats för att underlätta övertilldelning i börsintroduktionserbjudandet återfåtts

Published

02/05/2019 10:47

Contact

Name	Peter Benson, Merete Lundbye Møller
Phone	+4520126000	Email lundbye@sunstone.eu

*Source of information has chosen not to submit the data

CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25